Fat distribution and storage: How much, where, and how?

European Journal of Endocrinology

Volumn 157, Issue SUPPL. 1, 2007, Pages

  Weiss, Ram ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID; INSULIN; INTERLEUKIN 6;

ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; COMORBIDITY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FATTY ACID OXIDATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ABDOMINAL CAVITY; ADIPOSITY; HUMANS; INFLAMMATION; INTRACELLULAR MEMBRANES; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; TISSUE DISTRIBUTION;

EID: 34548742845     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0125     Document Type: Article

References (62)

1. Haslam DW & James WP. Obesity. Lancet 2005 366 1197-1209.
2. Hu FB, Stampfer JM, Haffner SM, Solomon CG, Willett WC & Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002 25 1129-1134.
3. Haffner SM. Epidemiology of insulin resistance and its relation to coronary artery disease. American Journal of Cardiology 1999 84 11J-14J.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607.
5. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. NIH Publication NO 01-3670. Bethesda, MD: National Institutes of Health, 2001.
6. Cersosimo E & DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes/ Metabolism Research and Reviews 2006 22 423-436.
7. Kuczmarski RJ & Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. American Journal of Clinical Nutrition 2000 72 1074-1081.
8. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS & Caprio S. Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine 2004 350 2362-2374.
9. Freedman DS, Mei Z, Srinivasan SR, Berenson GS & Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. Journal of Pediatrics 2007 150 12-17.
10. Druet C, Dabbas M, Baltakse V, Payen C, Jouret B, Baud C, Chevenne D, Ricour C, Tauber M, Polak M, Alberti C & Levy-Marchal C. Insulin resistance and the metabolic syndrome in obese French children. Clinical Endocrinology 2006 64 672-678.
11. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW & Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004 110 2494-2497.
12. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI & Caprio S. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003 362 951-957.
13. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI & Caprio S. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002 51 1022-1027.
14. Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, Tamborlane WV, Dziura J, Shulman GI & Caprio S. The 'obese insulin-sensitive' adolescent: importance of adiponectin and lipid partitioning. Journal of Clinical Endocrinology and Metabolism 2005 90 3731-3737.
15. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG & Shulman GI. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. PNAS 1995 92 983-987.
16. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M & Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999 42 113-116.
17. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW & Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003 300 1140-1142.
18. Petersen KF, Dufour S, Befroy D, Garcia R & Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New England Journal of Medicine 2004 350 664-671.
19. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White NW, Bilz S, Sono S, Pypaert M & Shulman GI. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. Journal of Clinical Investigation 2005 115 3587-3593.
20. Zderic TW, Davidson CJ, Schenk S, Byerley LO & Coyle EF. High-fat diet elevates resting intramuscular triglyceride concentration and whole-body lipolysis during exercise. American Journal of Physiology. Endocrinology and Metabolism 2003 286 E217-E225.
21. Helge JW, Watt PW, Richter EA, Rennie MJ & Kiens B. Fat utilization during exercise: adaptation to a fat-rich diet increases utilization of plasma fatty acids and very low density lipoprotein-triacylglycerol in humans. Journal of Physiology 2001 537 1009-1020.
22. Shulman GI. Cellular mechanisms of insulin resistance. Journal of Clinical Investigation 2000 106 171-176.
23. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF & Shulman GI. Free fatty acid-induccd insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999 48 1270-1274.
24. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G & Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. American Journal of Physiology 1999 276 E278-E284.
25. Jensen MD, Haymond MW, Rizza RA, Cryer PE & Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. Journal of Clinical Investigation 1989 83 1168-1173.
26. Koutsari C & Jensen MD. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. Journal of Lipid Research 2006 47 1643-1650.
27. Lebovitz HE & Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 2005 28 2322-2325.
28. Nielsen S, Guo Z, Johnson CM, Hensrud DD & Jensen MD. Splanchnic lipolysis in human obesity. Journal of Clinical Investigation 2004 113 1582-1588.
29. Tan GD, Goossens GH, Humphreys SM, Vidal H & Karpe F. Upper and lower body adipose tissue function: a direct comparison of fat mobilization in humans. Obesity Research 2004 12 114-118.
30. Guo Z, Hensrud DD, Johnson CM & Jensen MD. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999 48 1586-1592.
31. Fain JN, Madan AK, Hiler ML, Cheema P & Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 2273-2282.
32. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K & Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine 1996 2 800-803.
33. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA & Katsilambros N. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity Metabolism 1999 48 1332-1335.
34. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V & Hamsten A; the HIFMECH Study Group Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004 53 852-857.
35. Ridker PM & Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of framingham risk scores. Circulation 2004 109 1955-1959.
36. Bacha F, Saad R, Gungor N, Janosky J & Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. Journal of Clinical Endocrinology and Metabolism 2003 88 2534-2540.
37. Cruz ML, Bergman RN & Goran MI. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 2002 25 1631-1636.
38. Lee S, Bacha F, Gungor N & Arslanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 2006 29 51-56.
39. Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine 2002 16 1221-1231.
40. Ludwig J, Viggiano TR, McGill DB & Ott BJ. Nonalcoholic steatohepatitis: mayo clinic experience with a hitherto unnamed disease. Mayo Cinic Proceedings 1980 55 434-438.
41. Diraison F, Moulin P & Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes and Metabolism 2003 29 478-485.
42. Parks EJ & Hellerstein MK. Thematic review series: patient-oriented research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques. Journal of Lipid Research 2006 47 1651-1660.
43. Roberts E. Nonalcoholic steatohepatitis in children. Current Gastroenterology Reports 2003 5 253-259.
44. Lavine JE & Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clinics in Liver Disease 2004 8 549-558.
45. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I & Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Digestive Diseases and Sciences 1995 40 2002-2009.
46. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, Brunetti F & Rubino A. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Digestive Diseases and Sciences 1997 42 1428-1432.
47. Meltzer AA & Everhart JE. Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. American Journal of Epidemiology 1997 146 565-571.
48. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD & Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003 125 437-443.
49. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA & Caprio S. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. Journal of Clinical Endocrinology and Metabolism 2006 91 4287-4294.
50. Goodpaster BH, He J, Watkins S & Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. Journal of Clinical Endocrinology and Metabolism 2001 86 5755-5761.
51. He J, Goodpaster BH & Kelley DE. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obesity Research 2004 12 761-769.
52. Wellen KE & Hotamisligil GS. Inflammation, stress, and diabetes. Journal of Clinical Investigation 2005 115 1111-1119.
53. Leclerc V & Reichhart JM. The immune response of Drosophila melanogaster. Immunological Reviews 2004 198 59-71.
54. Bender B. Innate immunity: an overview. Molecular Immunology 2004 40 845-859.
55. Rajala MW & Scherer PE. The adipocyte at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 2003 144 3765-3773.
56. Matsuzawa Y, Funahashi T & Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines: adipocyte-derived bioactive substances. Annals of the New York Academy of Sciences 1999 892 146-154.
57. Taniguchi CM, Emanuelli B & Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nature Reviews. Molecular Cell Biology 2006 7 85-96.
58. Yudkin JS, Kumari M, Humphries SE & Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000 148 209-214.
59. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 1796-1808.
60. Pickup JC & Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia 1998 41 1241-1248.
61. Blake GJ & Ridker PM. Inflammatory biomarkers and cardiovascular risk prediction. Journal of Internal Medicine 2002 252 283-294.
62. Ford ES & National Health and Nutrition Examination Survey. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003 108 1053-1058.